Pilulka Lékárny a.s. (PINK.PR) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-148.4%

-CZK 41.63

vs CZK 86.00 price

Levered DCF

-CZK 34.44

After debt service

Piotroski score

—

Altman Z-score

—

Rating

—

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	0×	-2.31×	-3.81×	-25.5×	-167×	-67.63×	-28.6×	-48.92×
P/B	0×	-3.1×	20.27×	11.82×	20.83×	6.49×	14.44×	38.23×
P/S	0×	0.22×	0.31×	0.68×	1.79×	0.83×	0.95×	1.24×
EV / EBITDA	3.11×	-6.62×	-8.02×	563.38×	-3,756.94×	-389.05×	-29.98×	-52.08×
Gross margin	4.4%	8.8%	13.9%	10.6%	10.0%	11.1%	10.5%	10.2%
Operating margin	-1.1%	-7.8%	-7.0%	-1.9%	-0.6%	0.1%	-2.9%	-2.2%
Net margin	-4.4%	-9.6%	-8.2%	-2.7%	-1.1%	-1.2%	-3.3%	-2.5%
Current ratio	0.63×	0.45×	0.7×	0.93×	0.63×	0.83×	0.86×	0.88×
Debt / equity	-0.41×	-0.52×	2.34×	0.6×	0×	0×	0×	0×
Interest coverage	-0.55×	-8.22×	-14.17×	-10.01×	-18×	0.42×	-10.4×	-11.66×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	29.0%	133.8%	-532.6%	-46.3%	-12.5%	-9.6%	-50.5%	-78.2%
Return on invested capital	-38.9%	232.7%	-128.1%	-11.2%	-6.2%	0.5%	-29.9%	-32.0%
Return on assets	-19.7%	-53.0%	-39.8%	-10.7%	-4.3%	-4.4%	-11.1%	-8.2%
Free cash flow yield	0.0%	-22.4%	-10.5%	-6.9%	-1.3%	-1.4%	0.0%	0.0%
Earnings yield	0.0%	-43.2%	-26.3%	-3.9%	-0.6%	-1.5%	-3.5%	-2.0%
Enterprise value	CZK 39.7M	CZK 329.3M	CZK 732M	CZK 1.7B	CZK 4.2B	CZK 1.3B	CZK 1.2B	CZK 1.2B
Net debt / EBITDA	3.11×	-0.77×	-0.72×	20.99×	64.28×	38.09×	0.23×	0.56×
Cash conversion cycle (days)	-15	-11	-8	-5	27	22	24	27